Zevra Therapeutics, Inc. (ZVRA)
8.91
-0.18
(-1.98%)
USD |
NASDAQ |
Mar 03, 16:00
8.915
0.00 (0.00%)
After-Hours: 20:00
Zevra Therapeutics Research and Development Expense (Annual) : 35.71M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Ironwood Pharmaceuticals, Inc. | 93.26M |
| Verastem, Inc. | 81.33M |
| ADMA Biologics, Inc. | 4.762M |
| ACADIA Pharmaceuticals, Inc. | 328.80M |
| Alnylam Pharmaceuticals, Inc. | 1.320B |